Inactive Instrument

Calendar Acasti Pharma Inc Toronto S.E.

Equities

APO

CA00430K4028

Chart calendar Acasti Pharma Inc

559bf557b4e2964a3b82356041e.ehNF_3jVDz9ZYATUzXQghwS9gY_xy73-qB_FdLaY8fA.L1Yfl0ymdRItDWKstUFvyn7-0rq0vd-7nFmXEd__x7ZOWgysIYpLaBUkZw~47239d8bcb72c3b599220f1f9fd8c5aa

Upcoming events on Acasti Pharma Inc

18/06/2024 Q4 2024 Earnings Release (Projected)
08/08/2024 Q1 2025 Earnings Release (Projected)
11/11/2024 Q2 2025 Earnings Release (Projected)
17/02/2025 Q3 2025 Earnings Release (Projected)

Past events on Acasti Pharma Inc

12/02/2024 06:30 pm Q3 2024 Earnings Release
08/02/2024 International Stroke Conference
10/01/2024 LifeSci Partners Corporate Access Event
08/01/2024 Bio One On One Partnering Conference
07/01/2024 Sachs Neuroscience Innovation Forum
13/11/2023 06:30 pm Q2 2024 Earnings Release
11/10/2023 11:30 pm Investor Meeting - Key Openion Leader
10/10/2023 10:30 pm Annual General Meeting
11/09/2023 11:30 pm H.C. Wainwright Global Investment Conference
17/08/2023 03:30 am Neurocritical Care Society Meeting - Poster Number: 247
11/08/2023 04:30 pm Q1 2024 Earnings Release
23/06/2023 04:30 pm Q4 2023 Earnings Release
18/05/2023 11:30 pm Lytham Partners Spring Investor Conference - Panel
18/05/2023 06:30 pm Lytham Partners Spring Investor Conference
13/03/2023 06:10 pm Oppenheimer Healthcare Conference
14/02/2023 11:30 pm Q3 2023 Earnings Call
14/02/2023 05:30 pm Q3 2023 Earnings Release
31/01/2023 07:30 pm Lytham Partners virtual Investor Select Conference
19/01/2023 01:45 am Sidoti Micro-Cap Virtual Conference
11/01/2023 03:00 am GTX-101 and GTX-102 Phase 1 PK Studies Results Call

Annual results

Fiscal PeriodMarch 2019 2020 2021 2022 2023 2024
Net sales
Million CAD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00


0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Million CAD
Released
Forecast
Spread
-42,2
-18,3
-130.18%
0,00
0,00
-
0,00


0,00
0,00
-
0,00
0,00
-

-18,9

EBIT
Million CAD
Released
Forecast
Spread
-45,0
-43,9
-2.44%
-30,6
-35,9
14.87%
0,00


-20,3
-21,5
5.92%
-24,6
-27,2
9.74%

-16,3

Earnings before Tax (EBT)
Million CAD
Released
Forecast
Spread
0,00
0,00
-
-34,9
-68,1
48.68%
0,00


-13,6
-14,9
8.76%
-68,4
-27,2
-151.55%

-19,6

Net income
Million CAD
Released
Forecast
Spread
0,00
0,00
-
-34,9
-68,1
48.68%
-24,3


-12,8
-14,9
14.41%
-55,9
-26,3
-112.7%

-18,4

EPS
CAD
Released
Forecast
Spread
0,00
0,00
-
-19,7
-38,2
48.43%
-10,1


-2,09
-1,07
-96.04%
-7,53
-3,56
-111.24%

-1,94

Announcement Date26/06/1929/06/2022/06/2121/06/2223/06/23-

Quarterly results

Fiscal PeriodMarch 2022 Q3 2022 Q4 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales
Million CAD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00


0,00

EBITDA
Million CAD
Released
Forecast
Spread


















-4,10
-3,24
-26.37%

-4,97


-4,97


-5,64


-5,64


-5,64

EBIT
Million CAD
Released
Forecast
Spread
-5,67
-4,53
-25.4%
-5,72
-7,64
25.15%
-5,67
-7,79
27.27%
-6,01
-8,44
28.8%
-5,97
-6,63
10%
-2,89
-3,27
11.46%
-4,10
-3,51
-16.69%

-5,38


-5,38


-6,05


-6,05


-6,05

Earnings before Tax (EBT)
Million CAD
Released
Forecast
Spread
-4,79
-4,53
-5.89%
-5,91
-7,64
22.62%
-5,56
-7,86
29.25%
-50,0
-8,44
-491.99%
-5,78
-6,40
9.67%
-5,14
-3,10
-66.12%
-3,50
-3,51
0.34%

-5,38


-5,38


-6,05


-6,05


-6,05

Net income
Million CAD
Released
Forecast
Spread
-4,79
-4,53
-5.89%
-5,07
-7,64
33.64%
-5,19
-7,74
32.92%
-38,3
-8,44
-353.64%
-5,39
-6,21
13.13%
-4,53
-3,00
-50.7%
-3,22
-3,55
9.42%

-5,38


-5,38


-6,05


-6,05


-6,05

EPS
CAD
Released
Forecast
Spread
-0,69
-0,62
-11.31%
-0,31
-1,00
68.86%
-0,72
-1,02
29.25%
-5,15
-1,13
-356.66%
-0,72
-0,84
13.44%
-0,59
-0,40
-50.59%
-0,28
-0,31
9.09%

-0,47


-0,36


-0,42


-0,42


-0,32

Announcement Date14/02/2221/06/2214/02/2323/06/2311/08/2313/11/2312/02/24-----
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW